Ritonavir enables combined therapy with rifampin and saquinavir

被引：46

作者：

Veldkamp, AI

Hoetelmans, RMW

Beijnen, JH

Mulder, JW

Meenhorst, PL

机构：

[1] Stotervaart Hosp, Dept Pharm & Pharmacol, NL-1066 EC Amsterdam, Netherlands

[2] Stotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands

来源：

CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 06期

关键词：

D O I：

10.1086/313548

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1586 / 1586

页数：1

共 6 条

[1]

[Anonymous], 1998, MMWR Recomm Rep, V47, P1

[2] Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis [J].

Burman, WJ ;

Gallicano, K ;

Peloquin, C .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :419-429

[3]

Cameron DW, 1999, AIDS, V13, P213, DOI 10.1097/00002030-199902040-00009

[4] 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals [J].

Gazzard, B ;

Moyle, G .

LANCET, 1998, 352 (9124) :314-316

[5] Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial [J].

Kirk, O ;

Katzenstein, TL ;

Gerstoft, J ;

Mathiesen, L ;

Nielsen, H ;

Pedersen, C ;

Lundgren, JD .

AIDS, 1999, 13 (01) :F9-F16

[6] Current knowledge and future prospects for the use of HIV protease inhibitors [J].

Moyle, G ;

Gazzard, B .

DRUGS, 1996, 51 (05) :701-712

← 1 →